Loading...
You are here:  Home  >  Medical Marijuana  >  Current Article

Laura Bianchi, Rose Law Group partner and director of Medical Cannabis, talks to ‘Scottsdale Independent’ about medical marijuana and investment

Posted by   /  July 9, 2018  /  No Comments

    Print       Email

By Terrance Thornton | Scottsdale Independent

As Americans begin to come to terms with the ill effects of the pharmaceutical smörgåsbord offered for minor ailments to advanced critical illness, a new commodity is beginning to emerge in towns and cities across the nation.

From alternatives of the go-to-pain prescription — the opioid — and the shifting of perspectives, depending on who you ask, a new miracle drug is emerging: THC.

THC, which is short for tetrahydrocannabinol, is the principal psychoactive constituent of cannabis. In 1996, California became the first state to legalize medical cannabis, sparking a trend that has now touched many states.

Pills like this hydrocodone tablet are many peoples’ first introduction to the world of opiods that, in recent years, has translated into addiction, death and destruction. (file photo)

In 2016, 790 Arizonans died from opioid overdoses while zero deaths have been reported in Arizona as a result of medical marijuana use despite a rampant up-tick to those who seek the naturally occurring herb for consumption on a legal basis.

READ ON:

    Print       Email

Leave a Reply

You might also like...

Laura Bianchi, partner, director of Rose Law Group Medical Cannabis talks to KJZZ about marijuana hashish ruling

Read More →